Sha Huang
No 420 Fuma Road
Fuzhou, 350014, China
Fuzhou, 350014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction: Osthole induces accumulation of impaired autophagosome against pancreatic cancer cells.
Journal: Scientific reports
Published: March 10, 2026
Correction: Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: January 15, 2026
Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy.
Journal: Frontiers in immunology
Published: September 30, 2025
Identification of plasma lipidomic biomarkers for prognostic stratification in advanced gastric cancer treated with PD-1 inhibitor plus chemotherapy.
Journal: Frontiers in immunology
Published: September 27, 2025
Navigating hepatotoxicity of antibody-drug conjugates: from mechanistic insights to clinical and postmarketing evidence.
Journal: Frontiers in pharmacology
Published: August 28, 2025
Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis.
Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: August 01, 2025
Selection and validation of a cell-internalizing DNA aptamer targeting esophageal squamous cell carcinoma.
Journal: European journal of pharmacology
Published: July 29, 2025
Magnesium Isoglycyrrhizinate Combined With Steroid Is Superior to Steroid Monotherapy in Checkpoint Inhibitor-Induced Liver Injury.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 04, 2025
Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024).
Journal: Journal of clinical and translational hepatology
Published: May 18, 2025
A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer.
Journal: Therapeutic advances in medical oncology
Published: September 07, 2023
Last Updated: 09/26/2026